Carestream DRX-Revolution Mobile X-Ray System, Model DRXR-1, Catalog No. 1019397 (all other count...
FDA Device Recall #Z-1138-2017 — Class II — January 12, 2017
Recall Summary
| Recall Number | Z-1138-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 12, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Carestream Health Inc |
| Location | Rochester, NY |
| Product Type | Devices |
| Quantity | US: 1403 units; Foreign: 1370 units |
Product Description
Carestream DRX-Revolution Mobile X-Ray System, Model DRXR-1, Catalog No. 1019397 (all other countries), Catalog No. 1060177 (China only) -- Carestream Health, Inc. 150 Verona Street, Rochester, NY 14608
Reason for Recall
The firm received a complaint alleging that a DRX Revolution System could not be stopped when applying the brake. The Revolution crashed into an elevator.
Distribution Pattern
Worldwide Distribution - USA (nationwide) Distribution including Puerto Rico, and to the countries of : Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Dominican Republic, Dubai, Finland, France, Germany, Ghana, India, Iran, Ireland, Israel, Italy, Japan, Korea, Kuwait, Lebanon, Libya, Malaysia, Maldives, Mexico, Morocco, Netherlands, New Zealand, Norway, Oman, Peru, Poland, Portugal, Qatar, Russia, Saudi Arabia, Singapore, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates and United Kingdom.
Lot / Code Information
Serial Numbers: 101 to 2545 (Worldwide except China), 800101 to 800468 (China only)
Other Recalls from Carestream Health Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2651-2017 | Class II | DRX-Revolution Mobile X-Ray System; MODEL DRXR-... | May 25, 2017 |
| Z-1052-2017 | Class II | Carestream Touch Prime, Catalog # 1738830, and ... | Nov 21, 2016 |
| Z-2217-2016 | Class II | Carestream Touch Prime, Catalog Number 1738830,... | Jul 8, 2016 |
| Z-1594-2016 | Class II | CARESTREAM Image Suite V4; Image Suite V4: DIC... | Apr 15, 2016 |
| Z-1593-2016 | Class II | CARESTREAM Image Suite V3: MINI-PACS/F IMG ST/... | Apr 15, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.